Scientists are uncovering serotonin’s role in cancer – here’s what we know

Scientists are also exploring how serotonin produced in the gut reaches cancer cells. Understanding this pathway could allow ...

Why Winter Makes People Feel SAD; About Seasonal Affective Depression, And How To Tackle It

SAD is a clinical form of depression that follows a seasonal pattern. Most people experience its onset in late autumn or ...
Medical Dialogues

JnJ bags USFDA approval for Caplyta for major depressive disorder

Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA ...
Pharmaceutical Technology on MSN

J&J’s Caplyta wins MDD approval to extend revenue horizon

Caplyta (lumateperone) has scored a label extension into the depression setting, underscoring the belief Johnson & Johnson (J ...
Fierce Pharma

J&J's Caplyta supersizes its reach with FDA nod as add-on treatment for major depressive disorder

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...

Study suggests 3,000 steps a day is enough to boost brain health. Here’s how

Taking more than 5,000 steps each day could significantly slow cognitive decline and the build-up of proteins associated with ...

Neurologist reveals four ways walking can boost your brain

New research suggests that walking more than 5,000 steps every day may help slow cognitive decline and the accumulation of ...

How walking can boost your brain

New research suggests that walking more than 5,000 steps every day may help slow down cognitive decline and the build-up of a ...
Technology Networks

How Close Is MDMA to Becoming a Psychiatric Treatment?

Once dismissed as a party drug, MDMA is reemerging as a therapeutic option for treatment-resistant PTSD. Dr. Kenji Hashimoto ...